CarMax, Inc. (KMX) Income Statement

The acceleration is notable given that the 2025Q1 through 2026Q3 periods showed revenue growth oscillating between -7.5% and +6.7% — a range consistent with a demand environment struggling with elevated rates and constrained affordability. The two consecutive quarters of sequential revenue strength in 2027 suggest volume recovery rather than purely price-led growth, though the simultaneous decline in gross margin (discussed below) implies the company is buying volume through discounting rather than harvesting pricing power. Investors should monitor whether this pace is sustainable or reflects a pull-forward effect from tariff-related purchase timing.

This margin profile is also well below the 15.2% to 17.1% gross margins reported by franchised dealer peers such as AutoNation, Penske Automotive, and Asbury Automotive — a gap that partly reflects CarMax's pure used-vehicle concentration versus peers' higher-margin new-vehicle and fixed operations mix, but the direction of travel matters more than the level: margin compression during a demand recovery is the opposite of what a franchise dealer would experience. The 170 basis point swing from 2026Q1 to 2027Q1, followed by a modest recovery to 10.1%, suggests the trough may have passed, but the margin structure appears materially weaker than the pre-downturn baseline, and any further pricing concession could push the company back into operating losses.

The operating leverage math here is unforgiving: gross profit expanded from $785.2M in 2027Q1 to $799.5M in 2027Q2 (+14.3M), but SG&A only declined $6.6M over the same period, meaning roughly half the gross profit improvement was consumed by a modest step-down in overhead rather than flowing through to operating income at a leveraged rate. The more striking contrast is 2026Q4, when SG&A of $691.7M exceeded gross profit of $605.3M, producing a $249.7M operating loss — a signal that the cost base was built for a revenue level the company has only recently reclaimed. Whether this fixed-cost structure converts into operating leverage once revenue normalizes remains the central earnings question, and it appears the 2027 recovery is finally demonstrating that conversion.

The 2026Q4 loss appears to reflect the convergence of a seasonal revenue trough ($5.9B, down 1.0% year-over-year) with peak SG&A spending, and it marks the period where the cost structure and demand environment were most out of alignment. The recovery trajectory — from -$249.7M operating loss in 2026Q4 to +$236.3M operating income in 2027Q2, a $486M swing in two quarters — is meaningful, but investors should note that the recovery is being achieved on gross margins that remain below the 11.8% level of 2026Q1, meaning the operating income rebound is more volume-driven than margin-driven. If volume growth stalls while margins remain at 10% or lower, the fixed-cost base that produced the 2026Q4 loss becomes a direct earnings risk again.